1. SAT0143 A PHASE 1 STUDY IN HEALTHY VOLUNTEERS EXPLORING THE SAFETY, PHARMACOKINETICS AND PHARMACODYNAMICS OF ATI-450: A NOVEL ORAL MK2 INHIBITOR. (13th June 2020) Authors: Schnyder, J.; Monahan, J.; Smith, W.; Hope, H.; Kelly, D.; Burt, D.; Huff, E.; Kaul, A.; Hildebrand, A.; Burnette, B.; Klug, N.; Bangs, M.; Gordon, D. Journal: Annals of the rheumatic diseases Issue: Volume 79(2020)Supplement 1 Page Start: 1010 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗